| ZRG1 CN-Q (85) |
Immune Signaling in Neurological Disorders and Infectious Diseases |
Dr. Iqbal Sayeed |
| ZRG1 CN-U (55) |
RFA Panel: Optimizing Treatment Strategies for Adult ADHD |
Dr. Chi-Tso Chiu |
| ZRG1 CN-W (54) |
PAR's Panel: Rare Diseases Clinical Research Consortia |
Dr. Anita Tandle |
| ZRG1 CN-Y (81) |
Brain Injury and Neurodegeneration |
Dr. Alexander Yakovlev |
| ZRG1 CTH-H (50) |
PAR-23-242: NCI Research Specialist (Laboratory-based Scientist) Award (R50) |
Dr. Bruce Hissong |
| ZRG1 CTH-H (80) |
Mechanisms of Cancer Therapeutics Special Emphasis Panel. |
Dr. Bruce Hissong |
| ZRG1 CTH-N (55) |
PAR-24-306: Mammalian Models |
Dr. Susan Spence |
| ZRG1 CTH-P (40) |
IDeA Clinical and Translational Research Development (CTR-D) Award (P20/P50) |
Dr. Michael Opata |
| ZRG1 CTH-Q (45) |
Program Project: Cancer Research |
Dr. Michael Lindquist |
| ZRG1 CTH-T (81) |
Cancer Therapeutics and Drug Development
|
Dr. Lilia Topol |
| ZRG1 CTH-V (81) |
Clinical and Translational Cancer Research |
Dr. Viktoriya Sidorenko |
| ZRG1 CTH-X (81) |
Clinical and Translational Cancer Research |
Dr. Shuli Xia |
| ZRG1 CTH-Z (45) |
Program Project: Cancer Research |
Dr. Caterina Bianco |
| ZRG1 DCAI-B (50) |
PAR Panel: Review of Support for Research Excellence (SuRE) (R16) and SuRE-First Independent Research (SuRE-First) (R16) applications |
Dr. Shinako Takada |
| ZRG1 DCAI-D (02) |
Member Conflict: Topics in Infectious Diseases |
Dr. Dayadevi Jirage |
| ZRG1 DCAI-D (50) |
RFA-AI-25-022: Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease |
Dr. Dayadevi Jirage |
| ZRG1 DCAI-K (81) |
Infectious Disease Drug Development and Molecular Pharmacology |
Dr. Ekaterina Nestorovich |
| ZRG1 DCAI-S (40) |
RFA-25-035: Influenza Transmission Research Consortium |
Dr. Liangbiao Zheng |
| ZRG1 DCAI-V (89) |
Early Development of Vaccines Against Infectious Diseases |
Dr. Vanitha Raman |
| ZRG1 DCAI-X (80) |
Research Topics in Vector Borne Diseases and Co-infection and Cancer |
Dr. Hailey Weerts |
| ZRG1 DCAI-Z (51) |
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) |
Dr. Samita Andreansky |
| ZRG1 EMS-A (90) |
Endocrinology and Metabolism Topics |
Dr. Elaine Sierra-Rivera |
| ZRG1 EMS-G (55) |
High Impact, Interdisciplinary Science in NIDDK Research Areas AND Advancing Research on the Application of Digital Health Technology to the Management of Type 2 DM Study Section Meeting |
Dr. Dawanna James-Holly |
| ZRG1 EMS-G (80) |
Support for Research Excellence-SuRE and SuRE-First Study Section Meeting |
Dr. Dawanna James-Holly |
| ZRG1 EMS-H (50) |
PAR-25-438: Rare Diseases Clinical Research Consortia for the Rare Diseases Clinical Research Network |
Dr. Latha Malaiyandi |
